What Amgen actually looks for
Amgen, headquartered in Thousand Oaks, California, is one of the oldest and largest independent biotech companies, founded in 1980, and built its reputation on large-scale biologics manufacturing well before that became standard industry practice. Its major franchises include Enbrel for autoimmune conditions, Prolia and Xgeva for bone health, and Repatha for cholesterol management, alongside a growing push into the competitive obesity and metabolic disease space with its GLP-1-adjacent candidate MariTide, entering a market already dominated by Eli Lilly and Novo Nordisk. Because Amgen has decades of experience manufacturing complex biologic drugs at scale, interviewers in process development and manufacturing roles expect genuine technical depth on things like cell line development and bioreactor scale-up, not just general pharma knowledge. Amgen's long independent history, rather than being part of a larger pharma conglomerate, also shapes a culture that leans scientifically driven and somewhat more research-institution in feel than some larger diversified competitors.
Common questions and how to answer them
How would Amgen differentiate MariTide in a GLP-1 market already dominated by Lilly and Novo Nordisk? A thoughtful answer discusses MariTide's distinct dosing profile as a potential differentiator and acknowledges the real competitive difficulty of entering a market this saturated. Walk me through your understanding of large-scale biologics manufacturing challenges. Relevant for technical roles; discuss batch consistency, cell line stability, and the complexity of scaling up biologic production compared to small-molecule drugs. Amgen has been independent for decades rather than merging into a larger conglomerate. Why might that matter for how the company operates? Show you understand that this history has let Amgen build deep internal manufacturing and R&D capability rather than relying on frequent acquisition integration. For each question, be ready to go one level deeper technically than you might at a typical pharma company, since Amgen's manufacturing-heavy culture rewards genuine process knowledge over surface familiarity.
How to prepare
Understand Amgen's core franchises, Enbrel, Prolia/Xgeva, and Repatha, well enough to discuss their therapeutic areas specifically, and follow recent news on MariTide's clinical progress given how competitive the obesity drug space has become. If interviewing for manufacturing or process development, be ready for technically detailed questions about biologics production, since this is a genuine area of company strength and expertise. Research Amgen's history as one of biotech's original independent companies, since long-tenured employees often reference this identity directly in interviews. Expect technical interviews for manufacturing and process development roles to go deep on specific unit operations, since Amgen's interview bar reflects its decades of hands-on biologics manufacturing experience.